[Basic and clinical studies for IgG4 measurement by nephelometric immunoassay]

Area of Science:

• Immunology
• Gastroenterology
• Biochemistry

Context:

• Elevated serum IgG4 levels are increasingly recognized in autoimmune pancreatitis (AIP).
• Distinguishing AIP from pancreatic cancer is clinically challenging.
• Previous reports suggest IgG4's potential utility in differentiating these conditions.

Purpose:

• To evaluate the diagnostic utility of serum IgG4 levels in differentiating autoimmune pancreatitis (AIP) from pancreatic cancer, chronic pancreatitis, and other autoimmune diseases.
• To assess the reliability and accuracy of nephelometric immunoassay (NIA) for IgG4 measurement.

Summary:

• Serum IgG4 levels were measured in patients with AIP, chronic pancreatitis, pancreatic cancer, autoimmune diseases, and healthy individuals using nephelometric immunoassay (NIA).
• AIP patients exhibited significantly higher median IgG4 levels (247.0 mg/dl) compared to other groups.
• NIA demonstrated high precision with low analytical error (2.9%) and established reference ranges.
• The assay showed excellent performance in discriminating AIP from pancreatic cancer, with 87.0% sensitivity and 93.3% specificity.

Impact:

• Serum IgG4 measurement is a valuable and accurate tool for diagnosing autoimmune pancreatitis (AIP).
• This diagnostic capability can improve patient management and treatment strategies.
• Wider adoption may require more accessible assay systems like immunoturbidimetry.